↓ Skip to main content

Cochrane Database of Systematic Reviews

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

Overview of attention for article published in Cochrane database of systematic reviews, December 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
11 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
86 Mendeley
Title
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
Published in
Cochrane database of systematic reviews, December 2019
DOI 10.1002/14651858.cd004290.pub3
Pubmed ID
Authors

Deirdre Hahn, Elisabeth M Hodson, Lorraine A Hamiwka, Vincent WS Lee, Jeremy R Chapman, Jonathan C Craig, Angela C Webster

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 1%
Unknown 85 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 14%
Student > Master 12 14%
Researcher 9 10%
Other 8 9%
Student > Ph. D. Student 8 9%
Other 15 17%
Unknown 22 26%
Readers by discipline Count As %
Medicine and Dentistry 36 42%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Nursing and Health Professions 6 7%
Biochemistry, Genetics and Molecular Biology 3 3%
Unspecified 3 3%
Other 8 9%
Unknown 24 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2020.
All research outputs
#2,983,859
of 16,968,502 outputs
Outputs from Cochrane database of systematic reviews
#5,711
of 11,600 outputs
Outputs of similar age
#94,232
of 389,284 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 13 outputs
Altmetric has tracked 16,968,502 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,600 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.5. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 389,284 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.